Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein (original) (raw)
Desrosiers, R. C. et al. Identification of highly attenuated mutants of simian immunodeficiency virus. J. Virol.72, 1431–1437 (1998) CASPubMedPubMed Central Google Scholar
Fisher, A. G. et al. The sor gene of HIV-1 is required for efficient virus transmission in vitro. Science237, 888–893 (1987) ArticleADSCASPubMed Google Scholar
Gabuzda, D. H. et al. Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes. J. Virol.66, 6489–6495 (1992) CASPubMedPubMed Central Google Scholar
Simon, J. H. M. et al. The regulation of primate immunodeficiency virus infectivity by Vif is cell species restricted: a role for Vif in determining virus host range and cross-species transmission. EMBO J.17, 1259–1267 (1998) ArticleCASPubMedPubMed Central Google Scholar
Strebel, K. et al. The HIV “A” (sor) gene product is essential for virus infectivity. Nature328, 728–730 (1987) ArticleADSCASPubMed Google Scholar
von Schwedler, U., Song, J., Aiken, C. & Trono, D. vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J. Virol.67, 4945–4955 (1993) CASPubMedPubMed Central Google Scholar
Madani, N. & Kabat, D. An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein. J. Virol.72, 10251–10255 (1998) CASPubMedPubMed Central Google Scholar
Simon, J. H. M., Gaddis, N. C., Fouchier, R. A. M. & Malim, M. H. Evidence for a newly discovered cellular anti-HIV-1 phenotype. Nature Med.4, 1397–1400 (1998) ArticleCASPubMed Google Scholar
Foley, G. E. et al. Loss of neoplastic properties in vitro. II. Observations on KB sublines. Cancer Res.25, 1254–1261 (1965) CASPubMed Google Scholar
Nara, P. L. & Fischinger, P. J. Quantitative infectivity assay for HIV-1 and -2. Nature332, 469–470 (1988) ArticleADSCASPubMed Google Scholar
Hassaine, G. et al. The tyrosine kinase Hck is an inhibitor of HIV-1 replication counteracted by the viral vif protein. J. Biol. Chem.276, 16885–16893 (2001) ArticleCASPubMed Google Scholar
Camaur, D. & Trono, D. Characterization of human immunodeficiency virus type 1 Vif particle incorporation. J. Virol.70, 6106–6111 (1996) CASPubMedPubMed Central Google Scholar
Fouchier, R. A. M., Simon, J. H. M., Jaffe, A. B. & Malim, M. H. Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of _gag_-, _pol_-, and _env_-encoded proteins. J. Virol.70, 8263–8269 (1996) CASPubMedPubMed Central Google Scholar
Liu, H. et al. The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures. J. Virol.69, 7630–7638 (1995) CASPubMedPubMed Central Google Scholar
Teng, B., Burant, C. F. & Davidson, N. O. Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science26, 1816–1819 (1993) ArticleADS Google Scholar
Madsen, P. et al. Psoriasis upregulated phorbolin-1 shares structural but not functional similarity to the mRNA-editing protein apobec-1. J. Invest. Dermatol.113, 162–169 (1999) ArticleCASPubMed Google Scholar
Bhattacharya, S., Navaratnam, N., Morrison, J. R., Scott, J. & Taylor, W. R. Cytosine nucleoside/nucleotide deaminases and apolipoprotein B mRNA editing. Trends Biochem. Sci.19, 105–106 (1994) ArticleCASPubMed Google Scholar
MacGinnitie, A. J., Anant, S. & Davidson, N. O. Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity. J. Biol. Chem.270, 14768–14775 (1995) ArticleCASPubMed Google Scholar
Smith, A. A., Carlow, D. C., Wolfenden, R. & Short, S. A. Mutations affecting transition-state stabilization by residues coordinating zinc at the active site of cytidine deaminase. Biochemistry33, 6468–6474 (1994) ArticleCASPubMed Google Scholar
Dettenhofer, M., Cen, S., Carlson, B. A., Kleiman, L. & Yu, X.-F. Association of human immunodeficiency virus type 1 Vif with RNA and its role in reverse transcription. J. Virol.74, 8938–8945 (2000) ArticleCASPubMedPubMed Central Google Scholar
Khan, M. A. et al. Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA. J. Virol.75, 7252–7265 (2001) ArticleCASPubMedPubMed Central Google Scholar
Zhang, H., Pomerantz, R. J., Dornadula, G. & Sun, Y. Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process. J. Virol.74, 8252–8261 (2000) ArticleCASPubMedPubMed Central Google Scholar
Courcoul, M. et al. Peripheral blood mononuclear cells produce normal amounts of defective Vif- human immunodeficiency virus type 1 particle which are restricted for the preretrotranscription steps. J. Virol.69, 2068–2074 (1995) CASPubMedPubMed Central Google Scholar
Simon, J. H. M. & Malim, M. H. The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes. J. Virol.70, 5297–5305 (1996) CASPubMedPubMed Central Google Scholar
Sova, P. & Volsky, D. J. Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with _vif_-negative human immunodeficiency virus type 1. J. Virol.67, 6322–6326 (1993) CASPubMedPubMed Central Google Scholar
Pryciak, P. M. & Varmus, H. E. Fv-1 restriction and its effects on murine leukemia virus integration in vivo and in vitro. J. Virol.66, 5959–5966 (1992) CASPubMedPubMed Central Google Scholar
Fouchier, R. A. M., Meyer, B. E., Simon, J. H. M., Fischer, U. & Malim, M. H. HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import. EMBO J.16, 4531–4539 (1997) ArticleCASPubMedPubMed Central Google Scholar
Pear, W. S. et al. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood92, 3780–3792 (1998) CASPubMed Google Scholar
Simon, J. H. M. et al. The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells. J. Virol.71, 5259–5267 (1997) CASPubMedPubMed Central Google Scholar